[go: up one dir, main page]

FR2928545B1 - USE OF MONOAMINE OXIDASE INHIBITORS FOR CAPILLARY PIGMENTATION - Google Patents

USE OF MONOAMINE OXIDASE INHIBITORS FOR CAPILLARY PIGMENTATION

Info

Publication number
FR2928545B1
FR2928545B1 FR0851715A FR0851715A FR2928545B1 FR 2928545 B1 FR2928545 B1 FR 2928545B1 FR 0851715 A FR0851715 A FR 0851715A FR 0851715 A FR0851715 A FR 0851715A FR 2928545 B1 FR2928545 B1 FR 2928545B1
Authority
FR
France
Prior art keywords
monoamine oxidase
oxidase inhibitors
pigmentation
capillary
capillary pigmentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0851715A
Other languages
French (fr)
Other versions
FR2928545A1 (en
Inventor
Quentin Michard
Stephane Commo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0851715A priority Critical patent/FR2928545B1/en
Publication of FR2928545A1 publication Critical patent/FR2928545A1/en
Application granted granted Critical
Publication of FR2928545B1 publication Critical patent/FR2928545B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
FR0851715A 2008-03-17 2008-03-17 USE OF MONOAMINE OXIDASE INHIBITORS FOR CAPILLARY PIGMENTATION Expired - Fee Related FR2928545B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0851715A FR2928545B1 (en) 2008-03-17 2008-03-17 USE OF MONOAMINE OXIDASE INHIBITORS FOR CAPILLARY PIGMENTATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0851715A FR2928545B1 (en) 2008-03-17 2008-03-17 USE OF MONOAMINE OXIDASE INHIBITORS FOR CAPILLARY PIGMENTATION

Publications (2)

Publication Number Publication Date
FR2928545A1 FR2928545A1 (en) 2009-09-18
FR2928545B1 true FR2928545B1 (en) 2013-08-02

Family

ID=40029357

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0851715A Expired - Fee Related FR2928545B1 (en) 2008-03-17 2008-03-17 USE OF MONOAMINE OXIDASE INHIBITORS FOR CAPILLARY PIGMENTATION

Country Status (1)

Country Link
FR (1) FR2928545B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986664B2 (en) * 2010-10-15 2015-03-24 The Procter & Gamble Company Use of monoamine oxidase inhibitors to improve epithelial biology

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59204121A (en) * 1983-04-28 1984-11-19 Masumi Inaba Remedy for gray hair
FR2684300B1 (en) * 1991-11-29 1994-03-11 Lvmh Recherche COSMETIC OR PHARMACEUTICAL COMPOSITION, ESPECIALLY DERMATOLOGICAL, IN PARTICULAR FOR PROMOTING PIGMENTATION OF THE SKIN OR HAIR, CONTAINING A BALLOTE EXTRACT, AND ITS MANUFACTURING METHOD.
GB9215354D0 (en) * 1992-07-20 1992-09-02 Unilever Plc Cosmetic composition
EP0692972B2 (en) * 1993-04-02 2012-03-21 AntiCancer, Inc. Method for delivering beneficial compositions to hair follicles
ATE291902T1 (en) * 2000-08-01 2005-04-15 Sanofi Aventis PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION OF BEFLOTAXONE
JP2002226331A (en) * 2001-02-05 2002-08-14 Lion Corp Gray hair prevention / improvement agent
GB0127922D0 (en) * 2001-11-21 2002-01-16 Novartis Ag Organic compounds
NZ544851A (en) * 2003-06-23 2008-03-28 Macrochem Corp A vanishing cream base composition suitable for topical administration of an active agent to an animal or plant
FR2902320B1 (en) * 2007-01-22 2008-12-05 Oreal USE OF BUTYLATED HYDROXYANISOLE FOR THE TREATMENT OF CANITIA

Also Published As

Publication number Publication date
FR2928545A1 (en) 2009-09-18

Similar Documents

Publication Publication Date Title
EP2358748A4 (en) METHODS AND COMPOSITIONS FOR SPECIFIC MODULATION OF MCL-1
EP2320911A4 (en) VASOCONSTRICTION COMPOSITIONS, AND METHODS OF USE
EP2219671A4 (en) USE OF TAM RECEPTOR INHIBITORS AS TAM IMMUNOSTIMULATORS AND ACTIVATORS AS IMMUNOSUPPRESSANTS
EP2318377A4 (en) PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
EP2379561A4 (en) MLK INHIBITORS AND METHODS OF USE
EP2155818A4 (en) COMPOSITIONS SUITABLE FOR USE AS JOINT COMPOUNDS AND RELATED METHODS
EP1732904A4 (en) USE OF DIARYLTRIAZOLES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DESHYDROGENASE-1
EP2271349A4 (en) COMPOSITIONS AND METHODS FOR SKIN CARE
IL199738A0 (en) Inhibitors of d-amino acid oxidase
EP2192838A4 (en) HETEROCYCLIC INHIBITORS OF NECROPTOSIS
EP2512239A4 (en) BRIDGE BICYCLIC RHO-KINASE INHIBITORS, COMPOSITION AND USE
EP2084139A4 (en) OXAZOLIDINIUM COMPOUNDS AND USE AS HYDRATE INHIBITORS
EP2171096A4 (en) CARBOXYLESTERASE-1 POLYMORPHISMS AND METHODS OF USE
BRPI0811035A2 (en) FIBRINE COMPOSITIONS CONTAINING STRESS COMPOUNDS
FR2939039B1 (en) NEW SEBUM SECRET INHIBITOR AGENT
EP2344204A4 (en) TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
EP2164978A4 (en) COMPOSITIONS AND METHODS FOR MODULATING ADAMTS13 ACTIVITY
EP2387604A4 (en) CLEANING AGENTS FOR CLEANING DRILLING HOLES AND METHODS OF USE THEREOF
EP2326318A4 (en) SUR1 INHIBITORS FOR THERAPY
FR2991989B1 (en) COLORING MATERIALS OF VEGETABLE ORIGIN AND THEIR USE FOR COLORING COMPOSITIONS, ESPECIALLY COSMETIC COMPOSITIONS
ZA200906128B (en) Functionally sensitive alpha2c adrenoreceptor agonists
ME02999B (en) USE OF VAP-1 INHIBITORS FOR TREATING FIBROUS INJURIES
EP2483274A4 (en) ANTIPALUDITIC AGENTS INHIBITORS OF DIHYDRO-OROTATE DEHYDROGENASE
EP2262365A4 (en) USE OF -THIO-2'-DEOXYNUCLEOSIDES AS ANTI-ORTHOPOXVIRUS AGENTS
EP2184063A4 (en) USE OF LÉONURINE AND COMPOSITIONS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20161130